CBI’s 3rd Annual Forum on Oncology Commercialization Strategies

Starts: Thursday January 21, 2010 at 8:00am
Ends: Friday January 22, 2010 at 5:00pm
Event Type: Conference
Location: TBA
US
Price: $1395.00 - $1695.00
Website: https://www.cbinet.com/show_conference.cfm?confCode=PC10108&field=summary
Industry: medical device
Keywords: Commercialization Marketing Brand Management Product Management Reimbursement Managed Markets Medical Affairs Business Development New Product Planning Global Analytics Market Research Professional Relations National Accounts Sales
Intended For: You will benefit from attending this event if you are an executive or senior-level professional at a pharmaceutical, biotech or diagnostics company focused on oncology. This conference will also benefit consultants and technology providers with a focus i
Organization: The Center for Business Intelligence

In such a crowded and competitive market, the ability to differentiate your product and ensure the success of your commercial strategy has never been more important.

The oncology market continues to be the pharmaceutical industry’s fastest growing and largest therapeutic area. While there are many opportunities in this market, there is also a number of unique challenges companies face.

At this annual summit, hear about cutting-edge approaches used by the top manufacturers of oncology products for successful early stage partnerships and commercialization, effective sales and marketing and robust market access and reimbursement in this fast-moving, evolving market.

Topics being researched for 2010 include:

New product planning strategies for successful commercialization Launch strategies for entering a highly competitive market Oncology-specific sales and marketing initiatives Successful reimbursement and market access efforts, as well as the latest trends in patient support programs


For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.